---
title: "Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296266412.md"
description: "On August 14, 2026, Cytokinetics, Incorporated (Nasdaq: CYTK) based in South San Francisco, granted stock options for 27,565 shares of common stock and 18,273 restricted stock units (RSUs) to 12 new employees who started in July and August 2026. The RSUs will be converted to common stock upon vesting. This action was taken as a significant incentive for their employment, totaling 45,838 equity units granted."
datetime: "2026-08-18T20:01:36.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296266412.md)
  - [en](https://longbridge.com/en/news/296266412.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296266412.md)
generator: "portal-rs"
---

# Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

On August 14, 2026, Cytokinetics, Incorporated (Nasdaq: CYTK) based in South San Francisco, granted stock options for 27,565 shares of common stock and 18,273 restricted stock units (RSUs) to 12 new employees who started in July and August 2026. The RSUs will be converted to common stock upon vesting. This action was taken as a significant incentive for their employment, totaling 45,838 equity units granted.

### Related Stocks

- [CYTK.US](https://longbridge.com/en/quote/CYTK.US.md)

## Related News & Research

- [Cytokinetics grants new-hire equity awards, stock options priced at $74.13 per share](https://longbridge.com/en/news/296264145.md)
- [Top Cytokinetics Executive Makes Attention-Grabbing Move With Insider Stock Sale](https://longbridge.com/en/news/296290252.md)
- [Will MYQORZO Traction Amid Weaker Q2 2026 Results Change Cytokinetics' (CYTK) Narrative](https://longbridge.com/en/news/296006872.md)
- [Cytokinetics EVP R&D Malik Fady Ibraham disposes of 3,500 common shares for $265,370](https://longbridge.com/en/news/296267986.md)
- [Cytokinetics, Incorporated $CYTK Shares Purchased by Tema ETFs LLC](https://longbridge.com/en/news/295773794.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**